ArticleBrain : a journal of neurology2020

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine.

Judith A Pijpers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.